日清(01475.HK)首九個月溢利按年增26%至2.34億元
日清(01475.HK)公布,去年底止九個月溢利按年增長25.6%至2.34億元,收入按年增長3.2%至23.48億元。公司母公司NISSIN FOODS HOLDINGS CO., LTD.公布,其中國業務分部期間營業收入按年增長26.4%至30.39億日圓,銷售總額按年增長1.9%至317.66億日圓。
公司表示,高增值麵市場持續在中國大陸擴張,公司積極擴展其地域銷售面積並強化其合味道品牌,有賴於主要為合味道品牌杯麵的強勁銷售表現,銷售額按年錄得增加。溢利按年增加乃由於中國銷售量增加,以及來自銷售量增加相關的成本降低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.